The Chinese In Vitro Diagnostics Market is Forecast to Reach USD 22.3 Billion by 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “China In Vitro Diagnostics (IVD) Market, By Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, POCT, Coagulation) and Companies” report has been added to ResearchAndMarkets.com’s offering.

In China, the in vitro diagnostic industry has evolved since the 1980s, and now the key players are manufacturing from single and straight forward products to complete industrial chains. The 21st century brought a rapid development in China’s IVD industry, where all the tools such as reagents and instruments are produced in-house. The increasing number of test volumes related to clinical chemistry, immunoassay, haematology, coagulation and microbiology are in high demand. They are acting as a catalysing role for the growth of the China IVD industry. According to this report, China’s In Vitro Diagnostics Market will be USD 22.3 Billion by 2026.

The major growth drivers for China’s IVD industry are increasing demand from the middle class for high-quality healthcare products, and rising incidences of lifestyle diseases. In China, there has been massive expenditure in every healthcare segment in the areas of pharmaceuticals, medical devices, and traditional Chinese medicines. The significant barriers for China’s IVD industry is the lagging by local manufacturers in the adoption of advanced technology.

In October 2020, Roche diagnostics launched the product “Roche’s Tecentriq” with Avastin which was approved by CFDA for the treatment of liver cancer. The outbreak of Covid-19 has impacted IVD products by playing a vital role in the diagnosis of coronavirus symptoms.

This report studies the China IVD Industry and is broken down as follows:

By Segment – The Report Studies the Market of the following 8 Categories:

1. Clinical Chemistry
2. Immunoassay
3. Molecular Testing
4. Microbiology
5. Hematology
6. Self Monitoring of Blood Glucose (SMBG)
7. Point of Care Testing (POCT)
8. Coagulation

Key Players covered in the report which has been studied from 3 viewpoints:

1. Overview
2. Initiatives & Recent Developments
3. Revenue

Companies covered in this report:

1. Roche Diagnostics
2. Sysmex Corporation
3. Mindray Medical International Limited
4. Shanghai Kehua Bio-Engineering Co. Ltd.
5. Abbott Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/8bw7py

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900